NCT03251547View on ClinicalTrials.gov

Recombinant Activated Factor VII in the Management of Massive Bleeding in Hospital Universiti Sains Malaysia

CompletedOBSERVATIONAL
Enrollment

76

Participants

Timeline

Start Date

August 21, 2017

Primary Completion Date

October 15, 2017

Study Completion Date

November 15, 2017

Conditions
Massive HemorrhageMassive Blood LossMassive Blood Transfusion; Thrombocytopenia
Interventions
DRUG

NovoSeven

To survey retrospectively the treatment indications, clinical outcome, transfusion need and changes in coagulation profiles of non-haemophiliac patients who had received rFVIIa during massive bleeding

Trial Locations (1)

16150

Hospital Universiti Sains Malaysia, Kota Bharu

All Listed Sponsors
lead

Universiti Sains Malaysia

OTHER

NCT03251547 - Recombinant Activated Factor VII in the Management of Massive Bleeding in Hospital Universiti Sains Malaysia | Biotech Hunter | Biotech Hunter